Travere Therapeutics, Inc. · NASDAQ:TVTX
State Street Corp reported a 5.30% stake in Travere Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 5.30% stake in Travere Therapeutics, Inc., 4,756,666 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 4,756,666
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.30% | 4,756,666 |
Source
Related
- Travere Therapeutics, Inc.
- State Street Corp
- Travere Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026